Publication | Open Access
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern
17
Citations
15
References
2022
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1